Katsuyuki Shirai

Papers

Total Citations

H-Index

About

Katsuyuki Shirai is a leading figure in radiation oncology, with a focused expertise in prostate cancer treatment and the optimization of radiotherapy outcomes. His research centers on identifying predictive factors for prostate-specific antigen (PSA) recurrence following surgery and salvage radiotherapy, aiming to refine therapeutic strategies for high-risk patients. A notable contribution is his work on the cribriform pattern as a predictive factor for PSA recurrence in patients receiving radiotherapy after prostatectomy, a study published in 2024 that has already garnered 2 citations, signaling its emerging impact in the field. This research addresses a critical clinical challenge—recurrence after salvage radiotherapy—by providing histopathological insights that can guide personalized treatment planning. Shirai’s work bridges surgical and radiotherapeutic approaches, offering practical biomarkers to improve patient outcomes. His dedication to translating pathological findings into actionable clinical tools underscores his role in advancing precision oncology. For students and researchers, his studies represent a vital intersection of pathology and radiation therapy, highlighting how detailed tumor morphology can predict treatment response and ultimately reduce recurrence rates in prostate cancer patients.